Literature DB >> 26147150

Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.

Georgios Meletis1, Efstathios Oustas1, Christina Botziori1, Eleni Kakasi1, Asimoula Koteli1.   

Abstract

In 2010 the Hellenic center for disease control and prevention launched the "Prokroustes" nationwide action plan to tackle the increasing rates of carbapenem resistance among gram-negative nosocomial pathogens. In the present report, data from a Greek tertiary-care hospital are presented three years after the adoption of the infection control measures. Carbapenem resistance rates have been contained for Klebsiella pneumoniae and Acinetobacter baumannii but not for Pseudomonas aeruginosa. More worryingly, in accordance with their overuse against carbapenem-resistant bacteria, resistance rates to colistin and tigecycline have risen significantly.

Entities:  

Keywords:  Carbapenems; Colistin; Infection control; Tigecycline

Mesh:

Substances:

Year:  2015        PMID: 26147150

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  9 in total

Review 1.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

2.  Long-lasting austerity in the Greek health care system: Could it influence the efforts to limit the spread of carbapenem-resistance in Europe?

Authors:  G Meletis; D Chatzidimitriou
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

3.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 4.  Carbapenem resistance: overview of the problem and future perspectives.

Authors:  Georgios Meletis
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 5.  Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.

Authors:  Theodoros Karampatakis; Charalampos Antachopoulos; Athanassios Tsakris; Emmanuel Roilides
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-11       Impact factor: 3.267

Review 6.  Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis.

Authors:  Ulrike Binsker; Annemarie Käsbohrer; Jens A Hammerl
Journal:  FEMS Microbiol Rev       Date:  2022-02-09       Impact factor: 16.408

7.  Phenotypic Changes Associated With In Vivo Evolution of Colistin Resistance in ST11 Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Miaomiao Xie; Kaichao Chen; Ning Dong; Qi Xu; Edward Wai-Chi Chan; Rong Zhang; Sheng Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-02-24       Impact factor: 5.293

8.  A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.

Authors:  Sofia Maraki; Elpis Mantadakis; Viktoria Eirini Mavromanolaki; Diamantis P Kofteridis; George Samonis
Journal:  Infect Chemother       Date:  2016-09-09

Review 9.  Colistin Resistance in Enterobacterales Strains - A Current View.

Authors:  Elżbieta M Stefaniuk; Stefan Tyski
Journal:  Pol J Microbiol       Date:  2019-12-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.